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110Objective: During intraaortic balloon inflation, blood volume is displaced toward the heart (Vtip), traveling ret-
rograde in the descending aorta, passing by the arch vessels, reaching the aortic root (Vroot), and eventually per-
fusing the coronary circulation (Vcor). Vcor leads to coronary flow augmentation, one of the main benefits of the
intraaortic balloon pump. The aim of this study was to assess Vroot and Vcor in vivo and in vitro, respectively.
Methods: During intraaortic balloon inflation, Vroot was obtained by integrating over time the aortic root flow
signals measured in 10 patients with intraaortic balloon assistance frequencies of 1:1 and 1:2. In a mock circula-
tion system, flow measurements were recorded simultaneously upstream of the intraaortic balloon tip and at each
of the arch and coronary branches of a silicone aorta during 1:1 and 1:2 intraaortic balloon support. Integration
over time of the flow signals during inflation yielded Vcor and the distribution of Vtip.
Results: In patients, Vroot was 6.4%  4.8% of the intraaortic balloon volume during 1:1 assistance and 10.0%
 5.0% during 1:2 assistance. In vitro and with an artificial heart simulating the native heart, Vcor was smaller,
3.7% and 3.8%, respectively. The distribution of Vtip in vitro varied, with less volume displaced toward the arch
and coronary branches and more volume stored in the compliant aortic wall when the artificial heart was not op-
erating.
Conclusion: The blood volume displaced toward the coronary circulation as the result of intraaortic balloon in-
flation is a small percentage of the nominal intraaortic balloon volume. Although small, this percentage is still
a significant fraction of baseline coronary flow. (J Thorac Cardiovasc Surg 2010;140:110-6)The intraaortic balloon pump (IABP) provides mechanical
support to the heart in the preoperative, postoperative, and
intraoperative surgical setting and in the medical setting in
clinical conditions such as cardiogenic shock, myocardial
infarction, and unstable angina.1-4 The IABP is also often
used as a bridge to cardiac transplantation.3
The intraaortic balloon (IAB) starts to inflate immediately
after left ventricular (LV) ejection and completes deflation
before the onset of the following LV ejection. Accurate tim-
ing is essential for optimum IABP performance.
When the IAB is inflated it displaces blood volume up-
stream, toward the heart, increasing early diastolic aortic
pressure and providing a boost to coronary blood supply.
Similarly, when the IAB is deflated it draws blood volume
downstream, away from the heart, reducing end-diastolic
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The Journal of Thoracic and Cardiovascular Surgeffects related to these major outcomes are decreased LV
volume and LV systolic work, reduced end-diastolic and
peak-systolic aortic pressure, increased stroke volume, and
improved cardiac output.3
This study focused on the phase of IAB inflation and more
specifically on the blood volume displaced upstream during
inflation. In vivo studies report increased peak diastolic and
mean coronary flow velocity, and increased diastolic coro-
nary flow velocity integral in healthy coronary vessels,2,5-7
but reports on the blood volume flowing through the coro-
nary arteries as the result of inflation (Vcor) are scarce. A mi-
crosphere study in sheep reports Vcor of 0.1 mL/min/g in
myocardial tissue supplied by a nonstenotic artery,8 but
there are no comparable data in humans.
The IAB is placed in the descending aorta, between the
arch vessels and the renal arteries. During IAB inflation,
blood volume is displaced upstream of the IAB tip (Vtip),
travels retrograde in the descending aorta, passes by the
arch vessels, travels into the ascending aorta, arrives at the
aortic root (Vroot), and eventually is directed into the coro-
nary circulation as Vcor. Vroot, Vcor, and their relation to
Vtip are not adequately reported in the literature. Accord-
ingly, the aim of this study was to measure Vroot in humans,
as an indication of Vcor. A more detailed in vitro study in
a mock circulation was also conducted, in which the distri-
bution of Vtip in the aortic arch, coronary branches, and com-
pliant aortic wall was quantified.ery c July 2010
Abbreviations and Acronyms
CBF ¼ coronary blood flow
CPB ¼ cardiopulmonary bypass
IAB ¼ intraaortic balloon
IABP ¼ intraaortic balloon pump
LV ¼ left ventricular
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In Vivo Data
The study population consisted of 10 patients (7 men; mean age 56  5
years) who were supported by the IABP at least 2 days before open surgery
for ventricular assist device placement. The protocolwas approved by theHu-
man Subjects Protection Program Office of the University of Louisville, and
written informed consent was obtained from all patients. The data were avail-
able as part of an earlier study (American Heart Association award 0355187).
IAB catheters (Datascope Corp, Wayne, NJ) with a balloon size of 34 or
40 mL were inserted via the femoral artery and connected to the IABP (Sys-
tem 98 or CS100, Datascope Corp).
Patients were anesthetized according to a routine protocol, and anesthe-
sia was maintained with isoflurane. Simultaneous aortic (Pao) and LV (PLV)
pressure signals were recorded with a high-fidelity 5F dual-pressure-sensor
catheter (Millar Instruments, Houston, Tex). Flow (Qao) was measured at
the same location as Pao with a perivascular flow probe (Transonic Systems
Inc, Ithaca, NY). Pao and Qao were obtained at the aortic root, distal to the
coronary arteries. Hemodynamic data and electrocardiograms were re-
corded at 200 or 400 Hz.
In all patients, data were recorded before ventricular assist device place-
ment with IABP assistance frequencies of 1:1 and 1:2, and when the pump
was on standby. Timing of inflation and deflation was based on the aortic
pressure signal recorded internally by the pump with the fluid-filled catheter
incorporated in the IAB.
For each pump setting, data were collected continuously for approxi-
mately 15 seconds, and a few minutes were allowed between successive
measurements for hemodynamics to stabilize.
For each patient, a single representative beat was selected for each con-
dition. Figure 1 shows typical examples of Pao and Qao recordings during
a control and its following assisted beat from a 63-year-old male patient
(Figure 1, A) and a 60-year-old male patient (Figure 1, B). As can be de-
duced from the onset of the rapid increase in Pao during early diastole
with respect to the incisura, Figure 1, A, corresponds to a case of well-timed
inflation, whereas Figure 1, B, illustrates a case of fortuitous late inflation.
From the Qao measurements, Vroot was calculated by integrating over
time the negative peak during IAB inflation (Figure 1). Vroot was normalized
with respect to IAB volume to allow for comparing the results between pa-
tients assisted with different IAB sizes. Averages per beat were calculated
for Pao, Qao, and systolic PLV.
In Vitro Data
A physiologic distribution of resistance and compliance was applied
across a silicone aortic model (Ranier, Cambridge, UK) with 14 main
branches (celiac, splenic and left and right coronary, carotid, subclavian, re-
nal, femoral and deep femoral branches). Realistic values for terminal resis-
tance and compliance of each branch were obtained from the model
described by Stergiopulos and colleagues,9 after reducing their 55-branch
model to 14 branches by summing resistances and compliances according
to basic in parallel and in series electrical circuit concepts. Flow out of
each branch was directed to a common drainage tube that was connected
to an overhead water reservoir providing a head pressure of 10 mm Hg in
the silicone model.The Journal of Thoracic and CaAn extracorporeal LV assist device (BVS5000, Abiomed Inc, Danvers,
Mass) was used to simulate the native heart in vitro. It was driven with water
by a piston pump (Placepower, Norfolk, UK) and provided a cardiac output
of 2.7 L/min at a heart rate of 60 beats/min, working close to its maximum
capacity. The left ventricle of the artificial heart was connected to the aortic
root of the aortic model, and the left atrium was connected to the overhead
reservoir. The IABP was triggered by the piston pump.
Intraaortic balloons (Datascope Corp), sized 25 mL and 40 mL, were in-
serted via the left common femoral branch, advanced into the aorta until
their tips were just distal to the subclavian branch, and connected to the
IABP (System 97e, Datascope Corp).
Aortic pressure at the tip of the IAB (Ptip) was recorded with a solid-state
7F sensor-tipped catheter (Gaeltec Ltd, Isle of Skye, UK). Flows (Q) at the
tip of the IAB (Qtip) and through the carotid, subclavian, and coronary
branches were measured with 20-, 10-, 8-, and 3-mm flowprobes, respec-
tively (Transonic Systems Inc). Data were digitized and recorded at 500 Hz.
To assess the effect of the IAB inflation separately from the combined
effect of IAB inflation and diastolic recoiling of the aorta, recordings were
made with the IABP operating in 1:1 and 1:2 with and without the artificial
heart. When the balloon was simply pumping against standstill conditions,
the IABPwas driven by a patient simulator (System 90 Series IABP Trainer,
Datascope Corp) set at a heart rate of 60 beats/min. Steady-state intraaortic
pressure was 66 mm Hg to simulate mean diastolic pressure in patients.
Multiple beats were analyzed for each condition. Figure 2 shows typical
examples of Ptip and Qtip recordings during 1:2 assistance without (top) and
with the artificial heart (bottom) for a control and its following assisted beat.
The coronary, subclavian, and carotid Q measurements and Qtip were in-
tegrated with respect to time as shown in Figure 2 (for Qtip) to derive the
blood volume (V) displaced through the respective branches and upstream
of the IAB tip due to inflation. By subtracting Vtip from the nominal balloon
volume, we derived an approximation of the volume displaced downstream.
The volume displaced upstream of the IAB tip, Vtip, without going through
the coronary or arch branches, is stored in the compliant aortic wall and is
referred to as ‘‘Vcompliance.’’
Statistical Analysis
Data are expressed as mean  standard deviation. For the in vivo data,
results between assistance frequencies 1:1 and 1:2 and pump off were com-
pared with analysis of variance with repeated measures, followed by con-
trast analysis (SPSS v 15.0; SPSS Inc, Chicago, Ill). Because of the small
patient population, a more elaborate statistical analysis taking into account
possible interactions from factors such as balloon size, could not be per-
formed.
For the in vitro data, statistical comparisons were only made with and
without the artificial heart, for each balloon size and assistance frequency,
with unpaired t tests. Comparisons between the assistance frequencies or
the balloon sizes were not considered to be of important clinical information
and were not performed.RESULTS
In Vivo Results
Hemodynamic signals. Diastolic aortic pressure augmen-
tation during inflation was demonstrated by a steep increase
in the Pao signal of the assisted beat (Figure 1) and coincided
with a negative peak in Qao, induced by blood volume dis-
placement toward the aortic root. This peak was either over-
lapping with aortic retrograde flow (Figure 1, A) or followed
immediately after as a distinct second negative peak (Fig-
ure 1, B).
Volume displacement. During 1:1 assistance, Vroot was
6.4%  4.8% of the IAB volume and increased to 10.0%rdiovascular Surgery c Volume 140, Number 1 111
FIGURE 1. Hemodynamic waveforms in vivo during 1:2 IABP support
for a control (top) and an assisted (bottom) beat in 2 different patients (A,
B). Pao, aortic pressure (solid black); Qao, aortic flow (filled grey). In cases
of correctly timed inflation (A), Vroot was derived by subtracting the intrin-
sic backflow of the control beat from the backflow of the assisted beat (both
areas shaded in dark grey). In cases of late inflation (B), Vroot was derived
directly from the assisted beat by integrating the area shaded in dark grey.
FIGURE 2. Pressure (Ptip, solid black) and flow (Qtip, filled grey) in vitro
during 1:2 IABP assistance. The onset of inflation and deflation (indicated
by the arrows). A, No artificial heart is connected to the system. B, IABP is
synchronized to the artificial heart. Vtip was derived by integrating the area
shaded in dark grey in each case.
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the 2 assistance frequencies was not statistically significant
(P ¼ .16).
Hemodynamic parameters. With 1:1 assistance, mean Pao
increased by 11.2% (61.6  16.5 mm Hg vs 68.5  16.4
mm Hg, P< .005). The increase was 20.2% with 1:2 assis-
tance (58.8  17.1 mm Hg vs 70.7  17.9 mm Hg, P<
.0001) and was significantly higher with respect to 1:1 assis-
tance (P< .05). Mean systolic PLV significantly decreased
during 1:1 assistance by 8.7% (76.6  21.0 mm Hg vs
69.9  19.8 mm Hg, P< .0005), and similarly during 1:2112 The Journal of Thoracic and Cardiovascular Surgassistance there was a decrease of 4.6% (73.8  22.6 mm
Hg vs 70.4  20.7 mm Hg, P< .05). Mean Qao increased
significantly during 1:1 assistance by 26.4% (2.92  1.06
L/min vs 3.69  1.29 L/min, P < .01) and by 13.0%
(2.99  1.27 L/min vs 3.38  1.25 L/min, P< .05) during
1:2 assistance.In Vitro Results
Hemodynamic signals. Early diastolic pressure augmenta-
tion was evident in the Ptip recording (Figure 2, B) during
IAB inflation, similar to Figure 1. The same finding can
also be observed in Figure 2, A, but with no heart function.
Both with and without the artificial heart, inflation was ac-
companied by a peak in Qtip that was caused by fluid volume
displacement toward the aortic root.
Volume displacement. Figure 3 shows the percent distri-
bution of IAB-induced flow during inflation in the coronary,
carotid, and subclavian arteries, compliant aortic wall, and
downstream of the balloon without and with heart function
simulated by the artificial heart. The results correspond to
a 25-mL IAB at an assistance frequency of 1:2. Overall,
when the balloon was counterpulsating with the artificial
heart, less fluid volume was stored in the compliant aortic
wall (5.3 vs 11.1 mL) and more was displaced downstream
of the balloon (10.4 vs 7.9 mL) and overall through the arch
and coronary branches (9.3 vs 6.0 mL). The volume dis-
placed through both left and right coronary branches was
1.0 mL without the artificial heart and 0.9 mL with the
artificial heart.ery c July 2010
FIGURE 3. Percent distribution of the total volume displaced upstream
and downstream of a 25-mL IAB during inflation at 1:2 assistance without
(A) and with (B) the artificial heart connected to the in vitro setup. L, Left; R,
right.
FIGURE 4. Upper portion of the artificial aorta showing the tip of the IAB
and the approximate locations where flowwas measured in the coronary and
arch branches. The fluid volume that passed through each branch in vitro
because of the inflation of the 40-mL IAB at 1:1 frequency is noted both
for the cases with and without artificial heart connected to the system.
L, Left; R, right; IAB, intraaortic balloon.
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a 40-mL balloon during 1:1 IABP support without and
with heart function simulation. Similar to the findings illus-
trated in Figure 3, with the artificial heart, less fluid volume
was stored in the compliant aortic wall (14.0 vs 21.8 mL) and
more fluid volume was displaced downstream of the balloon
(13.8 vs 9.8 mL) and through the arch and coronary branches
(12.2 vs 8.4 mL). The total volume displaced through the
coronary branches was 1.8 mL as opposed to 1.5 mLwithout
the artificial heart. Qualitatively, these findings remainedThe Journal of Thoracic and Caconsistent between different balloon sizes and different
assistance frequencies (Table 1).DISCUSSION
This study shows that the blood volume displaced in vivo
toward the coronary circulation during IAB inflation is no
more than 10% of the nominal balloon volume. These re-
sults are in agreement with our in vitro data, demonstrating
that the fluid volume passing through the coronary branches
during inflation is less than 5% of the IAB volume. The in
vitro investigation further revealed that a large percentage
of the fluid volume displaced upstream of the IAB tip during
inflation is stored in the compliant aortic wall. This percent-
age was approximately 2 times higher when the artificial
heart was not simulating the native heart function.Augmentation of Coronary Perfusion During
Inflation
Both the in vivo and in vitro results show that Vroot and
Vcor, respectively, are only a small fraction of the total bal-
loon volume, with the rest of Vtip being distributed between
the arch branches and stored in the compliant aortic wall. In
humans, Vroot was 6.4% during 1:1 IABP support and
10.0%with 1:2 IABP support. In vitro and with the artificial
heart simulating heart function, Vcor was even smaller, 3.7%
and 3.8%, respectively.
Although Vroot in vivo and Vcor in vitro are small, an ad-
ditional blood volume of 1 to 2 mL per beat in the coronary
circulation is a significant increase to baseline coronary
blood flow (CBF). In humans with healthy coronary vessels,
a mean CBF of 200 mL/min and heart rate of 75 beats/min10
provide approximately 2.5 mL of blood to the coronary cir-
culation during each heart cycle. Therefore an augmentationrdiovascular Surgery c Volume 140, Number 1 113
TABLE 1. Mean volume distribution for the 25-mL and 40-mL balloons
Balloon 25mL Balloon 40mL
1:1 1:2A 1:1 1:12A
Volume (mL) No heart Heart No heart Heart No heart Heart No heart Heart
R subclavian 1.09  0.10* 0.98  0.08 1.02  0.15 1.05  0.17 1.70  0.15 1.62  0.32 1.49  0.16* 2.03  0.31
L subclavian 1.21  0.12* 0.95  0.19 1.12  0.11* 0.83  0.13 1.79  0.14 1.87  0.39 1.65  0.21 1.57  0.27
R carotid 0.96  0.03* 3.45  0.06 1.35  0.03* 3.54  0.08 1.54  0.05* 4.13  0.04 1.94  0.12* 4.59  0.06
L carotid 1.00  0.03* 3.04  0.14 1.55  0.03* 2.98  0.03 1.61  0.05* 3.15  0.08 2.11  0.04* 3.37  0.05
R coronary 0.47  0.01 0.48  0.01 0.43  0.01* 0.50  0.01 0.90  0.01* 0.82  0.01 0.75  0.01* 0.85  0.01
L coronary 0.58  0.00* 0.44  0.01 0.56  0.01* 0.44  0.01 0.87  0.02* 0.65  0.01 0.74  0.05* 0.66  0.01
Upstream 17.39  0.92* 15.13  0.89 17.14  1.10* 14.61  0.20 30.22  2.18* 26.25  0.90 27.10  1.45 26.18  0.89
Volume (in milliliters) displaced into the arch and coronary branches and upstream of the IAB tip in vitro as the result of IAB inflation at different assistance frequencies, without
(No heart) and with (Heart) the artificial heart. Mean values for the subclavian branches and aorta are based on 16measurements, whereas 8measurements are available for the other
branches. *P< .005, comparing no heart with heart. R, Right; L, left.
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increase in CBF.
Augmentation of coronary perfusion during IABP sup-
port has been quantified in a microsphere study in sheep.8
The authors measured myocardial perfusion using micro-
spheres in myocardial regions supplied by an obstructed ar-
tery or by normal vessels. Measurements were taken at
control conditions and during IABP counterpulsation with
a 40-mL IAB. In the regions supplied by healthy coronary
vessels, CBF was 0.55 mL/min/g at control and 0.65 mL/
min/g during counterpulsation. For an average heart weight
of 300 g, coronary perfusion would therefore be 2.75 mL at
baseline and 3.25 mL with IABP support. Despite the differ-
ences in the experimental settings that make a direct quanti-
tative comparison of these results with ours difficult, both
studies are in agreement that the percentage of IAB volume
that reaches the coronary circulation is small and that this
small percentage is a large contribution to baseline coronary
perfusion.
Our in vitro measurements were obtained in unobstructed
branches; therefore, it would be difficult to extrapolate the
above observations to stenotic coronary vessels. In the pres-
ence of a stenosis, the effect of the IABP on CBF depends
inversely on the severity of the stenosis, with the potential
of even a reduction in CBF in cases of severe stenoses.11-14
Our findings on Vroot in vivo and Vcor in vitro projected into
the surgical setting suggest that IABP assistance may be par-
ticularly beneficial after coronary artery bypass grafting to
improve coronary perfusion in the immediate postoperative
period, when the heart is stunned after cardioplegia, cardio-
pulmonary bypass (CPB), and the consequent inflammatory
cascade.
Intraaortic Balloon Volume Distribution
Vtip has been quantified in vitro in a straight latex tube for
different IAB sizes, and it was approximately 57% of the
nominal balloon volume.15 Head pressure was 24 mm Hg,
and the IAB was operated from standstill. In view of the dif-
ferent experimental settings, these results are not substan-114 The Journal of Thoracic and Cardiovascular Surgtially different from those of the present study, in which
Vtip was 72.6% at 1:1 and 68.1% at 1:2 without the artificial
heart and 63.1% at 1:1 and 62.0% at 1:2 with the artificial
heart.
Figures 3 and 4 and Table 1 show the detailed distribution
of Vtip at different aortic branches in vitro. Corresponding
qualitative data are not available in vivo, but from published
studies on the differences between nonpulsatile and IABP-
induced pulsatile perfusion during CPB, it is possible to
qualitatively discern the net effect of the IABP on the perfu-
sion of different organs and vascular beds. For example, in-
creased tissue oxygen pressure in the renal medulla and
decreased local lactate levels have been found in CPB
with IABP.16 On the other hand, CPB without IABP has
been associated with renal hypoxia and acidosis.17,18 Like-
wise, progressive systemic arterial vasoconstriction has
been demonstrated in the absence of IABP, leading to re-
duced perfusion and acidosis.19 Similar findings have
emerged from studies of the splanchnic circulation, with re-
duced frequency of elevated amylase levels observed in pa-
tients receiving CPB with IABP.20 IABP during CPB
preserves the liver, decreasing aspartate aminotransferase
leakage.21 More recently, the benefit of IABP during CPB
has been investigated in an elderly population by Onorati
and colleagues.22 A significant improvement in respiratory
function was found, and it was concluded that IABP-in-
duced pulsatile flow significantly improves whole-body per-
fusion.
Volume Storage in the Aorta In Vitro
It was not possible to determine the distribution of stored
volume along the compliant aortic wall in vitro, but, merely
because of size, it can be speculated that the larger storage
capacity lies in the upper aorta, in the portion upstream of
the IAB tip. The length of this segment in the silicone aorta
was 17 cm, with an average diameter of 24 mm. Measure-
ments with ultrasonic crystals of the diameter of the upper
descending sheep aorta during IAB counterpulsation
showed an increase of 4.4% between systolic diameterery c July 2010
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crease of 4.4% in the mean diameter of the 17-cm segment
of the silicone aorta can be translated to an increase of 6.5
mL of its total volume capacity during inflation. This volume
is not dissimilar to the results of our in vitro study, showing
volumes of 5.79 mL during 1:1 assistance and 5.29 mL dur-
ing 1:2 assistance stored in the compliant aortic wall during
the inflation of a 25-mL IAB. The corresponding volumes
for a 40-mL IAB are larger, most likely because the aortic
model was overstretched during IAB inflation in a way
that would have been prevented in vivo by using a smaller
IAB size.
Effect of Heart Function on Intraaortic Balloon
Counterpulsation
When the IAB was counterpulsating with the artificial
heart, Vtip was smaller than when operating without the arti-
ficial heart. However, overall more volume was distributed
to the arch and coronary branches and less was stored in
the compliant aortic wall. This effect is clearly demonstrated
in Figures 3 and 4 and in Table 1.
Because there is minimal diastolic or no flow in the aorta
during IAB inflation in both in vitro setups, this difference in
volume distribution can be associated with a difference in
compliance.3 When IAB inflation follows a cardiac systole,
because of the Windkessel effect taking place in the aorta
during diastole, the elastic aortic wall will be recoiling at
the same time the inflating balloon is trying to expand it.
As a result of these opposing actions, aortic compliance is
lower and the fluid volume that can be stored in the aortic
wall is less than the volume that can be stored when the aorta
can freely expand during inflation. The fluid volume not
stored in the compliant aortic wall in the presence of heart
function is then distributed elsewhere (Figures 3 and 4).
The discharging of the fluid volume stored in the compliant
aortic wall is demonstrated in Figure 2, A, by the exponential
increase in Ptip between 15.5 and 16.5 seconds.
This result indirectly underlies the importance of arterial
compliance on IABP performance. These findings are in
agreement with previous studies stating that the efficiency
of the IAB is limited in highly compliant aortas.24
The in vitro experiment without the artificial heart simu-
lated the clinical setting of CPB and aortic crossclamping,
with the IABP providing pulsatile flow. Although standard
CPB with nonpulsatile flow is routinely used in surgical
practice, the added benefits of pulsatile perfusion include
improvement in organ perfusion caused by a reduction of va-
soconstrictive reflexes, improved oxygen consumption, and
a reduction of acidosis.19
Effect of Assistance Frequency In Vivo
The blood volume displaced toward the coronary circula-
tion during the assisted beat of the 1:2 support is less than
the combined volumedisplaced by2 consecutive beats duringThe Journal of Thoracic and Ca1:1 support. Although the results are not statistically signifi-
cantly different for this patient population, it is possible that
in a larger population differenceswould bemore pronounced.
Methodological Considerations and Limitations
It is expected that the reduction in systolic PLV during 1:1
assistance in patients will induce coronary vasoconstriction
because of the reduced myocardial oxygen demand,25 and
therefore reduce CBF, whereas on the other hand volume
displacement caused by inflation simultaneously tends to in-
crease it. This mechanism could not be duplicated in vitro,
and it is difficult to predict how this practically affected
Vcor. Other in vivo pathologic indications for using the
IABP, such as cardiogenic shock and unstable refractory an-
gina, were also not simulated, because they involve sympa-
thetic and parasympathetic nervous activities that could not
be replicated in vitro.
CONCLUSIONS
The blood volume displaced toward the coronary circula-
tion as the result of IAB inflation is only a small percentage
of the nominal IAB volume. However small this percentage
might be compared with the IAB volume, it is still a signifi-
cant percentage of baseline coronary perfusion.
The authors thank Giovanni Biglino, PhD candidate, for build-
ing the experimental setup used for the in vitro measurements in
collaboration with Christina Kolyva. Technical support with man-
agement of the clinical data was provided by Dr Guru Giridharan.
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